Jiangsu Nanfang Medical Co., Ltd. (603880.SS)
CNY 4.92
(-2.38%)
CNY 4.92
(-2.38%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 600.09 Million CNY | 10.03% |
| 2022 | 545.36 Million CNY | 3.4% |
| 2021 | 527.44 Million CNY | -50.82% |
| 2020 | 1.07 Billion CNY | 118.11% |
| 2019 | 491.68 Million CNY | 2.47% |
| 2018 | 479.82 Million CNY | -1.82% |
| 2017 | 488.7 Million CNY | 10.01% |
| 2016 | 444.23 Million CNY | 2.59% |
| 2015 | 433.02 Million CNY | -7.83% |
| 2014 | 469.8 Million CNY | -8.03% |
| 2013 | 510.79 Million CNY | 20.3% |
| 2012 | 424.62 Million CNY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q3 | 151.69 Million CNY | -4.64% |
| 2024 Q1 | 137.54 Million CNY | 5.98% |
| 2024 Q2 | 160.65 Million CNY | 16.8% |
| 2023 Q2 | 126.73 Million CNY | -43.95% |
| 2023 Q1 | 226.13 Million CNY | 48.5% |
| 2023 FY | 600.09 Million CNY | 10.03% |
| 2023 Q4 | 129.78 Million CNY | 10.51% |
| 2023 Q3 | 117.44 Million CNY | -7.34% |
| 2022 Q3 | 137.37 Million CNY | 21.93% |
| 2022 Q2 | 112.67 Million CNY | -21.23% |
| 2022 Q1 | 143.04 Million CNY | 17.07% |
| 2022 FY | 545.36 Million CNY | 3.4% |
| 2022 Q4 | 152.28 Million CNY | 10.85% |
| 2021 Q4 | 122.18 Million CNY | -14.48% |
| 2021 Q3 | 142.88 Million CNY | 18.39% |
| 2021 Q1 | 141.68 Million CNY | -12.46% |
| 2021 FY | 527.44 Million CNY | -50.82% |
| 2021 Q2 | 120.68 Million CNY | -14.82% |
| 2020 FY | 1.07 Billion CNY | 118.11% |
| 2020 Q4 | 161.85 Million CNY | -10.8% |
| 2020 Q1 | 100.43 Million CNY | -28.26% |
| 2020 Q2 | 628.65 Million CNY | 525.93% |
| 2020 Q3 | 181.45 Million CNY | -71.14% |
| 2019 Q3 | 128.45 Million CNY | 4.68% |
| 2019 FY | 491.68 Million CNY | 2.47% |
| 2019 Q4 | 140 Million CNY | 8.99% |
| 2019 Q1 | 100.51 Million CNY | -22.36% |
| 2019 Q2 | 122.71 Million CNY | 22.09% |
| 2018 Q3 | 119.57 Million CNY | 7.08% |
| 2018 FY | 479.82 Million CNY | -1.82% |
| 2018 Q4 | 129.45 Million CNY | 8.26% |
| 2018 Q2 | 111.67 Million CNY | -6.25% |
| 2018 Q1 | 119.12 Million CNY | -7.14% |
| 2017 FY | 488.7 Million CNY | 10.01% |
| 2017 Q1 | 105.74 Million CNY | -5.84% |
| 2017 Q2 | 134.44 Million CNY | 27.15% |
| 2017 Q3 | 120.24 Million CNY | -10.57% |
| 2017 Q4 | 128.27 Million CNY | 6.68% |
| 2016 FY | 444.23 Million CNY | 2.59% |
| 2016 Q4 | 112.3 Million CNY | 3.79% |
| 2016 Q3 | 108.2 Million CNY | -3.27% |
| 2016 Q2 | 111.86 Million CNY | 0.0% |
| 2016 Q1 | 111.86 Million CNY | 0.0% |
| 2015 FY | 433.02 Million CNY | -7.83% |
| 2014 FY | 469.8 Million CNY | -8.03% |
| 2013 FY | 510.79 Million CNY | 20.3% |
| 2012 FY | 424.62 Million CNY | 0.0% |